| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e1d55030a51d67b43dc5e43bfc0cde5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dd98ad4ee076841fec541542f952f58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f69477e064ada728eda5f7ffedf835e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0e8c1569e244cbbc287053b52b396bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_416b4253338890b8e4af5a53be18325f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27aa929f9bc7114c2901dc0ce982d37a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e26024afc9496cab58281da5e178c3ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04f657a8261a2fc879c089c99e63eb0b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-916 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2009-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bea8eb448a967c13afcff912cdd6f16f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a64a3a680ddad413c98d95b514ec0b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2870927205030979c0445c3ea8e36aff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8cf82de543bb95ff2602370c1987793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2c7254e23aaa6e6e8e8b184248f0ac8 |
| publicationDate |
2010-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010011310-A1 |
| titleOfInvention |
Methods for diagnosis and prognosis of skin cancer |
| abstract |
A method for diagnosing an early stage melanoma which includes detecting the expression level of dual specificity phosphatase 1 protein (DUSP1) and a method for determining a prognosis for a subject having melanoma which includes detecting the expression level of DUSP1 are disclosed. Also disclosed are pharmaceutical compositions and kits comprised by these methods. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10260104-B2 |
| priorityDate |
2008-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |